Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
3.46 HKD | +4.85% | +13.44% | -5.21% |
04-25 | Abbisko Cayman's Liver Cancer Drug Gets US FDA Orphan Drug Designation | MT |
04-24 | Abbisko Cayman Limited Announces Resignation of Tian Huimin as Joint Company Secretary | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-5.21% | 273M | |
-1.17% | 104B | |
+2.87% | 97.47B | |
+2.13% | 22.25B | |
-14.77% | 21.68B | |
-8.79% | 18.2B | |
-39.98% | 17.02B | |
-13.21% | 16.36B | |
+8.55% | 14.39B | |
+35.75% | 12.37B |
- Stock Market
- Equities
- 2256 Stock
- News Abbisko Cayman Limited
- Abbisko Therapeutics Doses First Patient in Giant Tumor Drug Trial in China; Shares Rally 3%